Compare
CVS Health vs Progyny (CVS vs PGNY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year CVS Health (CVS) returned +6.8% and Progyny (PGNY) +84.5%; so far this year the figures are +5.7% and +35.7%.
CVS Health is the larger company by market value, about 41.7 times the size of Progyny.
On trailing earnings, CVS trades at 9.7 times and PGNY at 32.0 times.
Revenue grew +6.7% at CVS and +5.5% at PGNY over the last year.
CVS yields 3.17%. PGNY pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| CVS | PGNY | |
|---|---|---|
| Price | $83.85 | $34.84 |
| 1-day | +3.10% | +1.37% |
| YTD | +5.66% | +35.67% |
| 1 year | +6.75% | +84.53% |
| 3 years | +22.00% | +14.49% |
| Market cap | $107.3B | $2.6B |
| P/E | 9.7 | 32.0 |
| P/S | 0.26 | 1.92 |
| P/B | 1.33 | 6.20 |
| Revenue growth | +6.70% | +5.50% |
| EPS growth | +2107.70% | +73.00% |
| Gross margin % | 44.2 | 24.9 |
| Net margin % | 2.6 | 6.8 |
| ROE % | 13.7 | 22.0 |
| Debt / equity | 0.75 | 0.00 |
| FCF yield % | 14.5 | 7.0 |
| Dividend yield % | 3.17 | — |
| Beta | -0.06 | -0.08 |
| RSI (14) | 39.9 | 80.3 |
| Technical rating |